Takeda plans to launch its dengue vaccine, Qdenga, in India by next year, partnering with Biological E to support the 'Make-in-India' initiative. The company will employ a tiered pricing model to ...

For a better experience, Read this story in our AppRead this story in our App ...

People who are given a vaccine for shingles -- zoster vaccine -- have a 23 per cent lower risk of cardiovascular events, incl ...

Vaccinating pregnant women against whooping cough can boost the quantity and quality of antibodies in the early life of ...

India's first dengue vaccine, expected to launch in 2026 after local trials; WHO-approved jab offers two-dose protection ...

Getting vaccinated against shingles could lower the chances of a cardiovascular event, such as stroke or heart failure, by 23 per cent, according to a study.     Protective effects of the vaccine for ...

Vaccines have saved 38 million lives in South-East Asia, including India, said World Health Organization (WHO) on Tuesday, as ...

WHY VACCINE LOCATION MATTERS Vaccines work by introducing a harmless form of a virus or bacteria into the body, teaching the ...

It is vitally essential to understand these misconceptions and present accurate facts on immunisation. Knowing the facts on ...

Gennova has been working on self-amplifying mRNA vaccine. mRNA vaccines use body’s machinery to make antigenic protein rather ...

Vaccinating pregnant women against whooping cough significantly enhances the protection of newborns in their early months, a ...

Congress MP Shashi Tharoor, a four-time lawmaker from Kerala's Thiruvananthapuram, said he "managed to land in time" to ...